2024-515150-24-00招募中1 期
A Phase 1 Study on the effects of LY3410738 (study drug) administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 3
- 试验地点
- 4
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Eli Lilly & Co.
Scientific
Eli Lilly & Co.
研究点 (4)
Loading locations...
相似试验
招募中
1 期
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)Rheumatoid ArthritisSystemic Lupus ErythematosusNCT07276958Eli Lilly and Company68
招募中
1 期
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid ArthritisNCT07258849Eli Lilly and Company141
招募中
1 期
A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment2025-521947-19-00Eli Lilly & Co.26
招募中
2 期
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic PainNCT07285018Eli Lilly and Company150
招募中
2 期
A dose finding study of LY3884961 in patients with Gaucher disease2022-500281-10-02Prevail Therapeutics Inc.6